Lomustine Capsule
Lomustine is a compounded formulation containing Lomustine, prepared by Mixlab for veterinary use. Available by prescription.
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Lomustine, also known as CCNU, is an alkylating nitrosourea agent utilized in veterinary medicine for its antineoplastic properties. It is a prescription medication available for use in dogs and cats, requiring professional guidance and monitoring by a licensed veterinarian. It is frequently considered in the context of oncology for patients presented with lymphoma, mast cell tumors or brain tumors.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is considered for its role in managing cell replication by inducing DNA cross-linking, providing a method for influencing the growth of cancer cells. Commonly observed effects include localized digestive changes such as vomiting or diarrhea and behavioral shifts like lethargy. A significant clinical consideration is the potential for delayed bone marrow suppression or liver sensitivity; your veterinarian will monitor for observational signs through frequent blood work. Owners should monitor for pale gums or unusual bruising and contact their veterinarian promptly with any concerns.
Yes. Lomustine is a prescription chemotherapy medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before any medication is prepared.
Yes. Mixlab specializes in compounding lomustine into customized strengths and flavored oral formats, such as capsules, to suit the specific needs of your pet. The decision rests with your prescribing veterinarian.
Veterinarians recommend frequent blood work to monitor the bone marrow's physiological response, which may occur several days after a dose. This provides a method for ensuring the management approach remains safe.
Because lomustine is a chemotherapy agent, your veterinarian will recommend wearing gloves when handling the medication. This provides a method for preventing accidental absorption during the management course.
Veterinarians discuss lomustine in the context of brain tumors because it is lipid-soluble and may cross the blood-brain barrier. Your veterinarian will determine if it is appropriate for your pet's specific oncological challenge.
